QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360)

Abstinence, Sex, Addiction Disorders, ADHD, ADHD - Attention Deficit Disorder With Hyperactivity, Alcohol Abuse/Dependence, Alcohol Addiction, Alcohol and Other Drug Use Disorders, Alcohol and Other Substance Use Prevention, Anger Problems, ASD, Asperger Disorder, Asperger's Disorder, Autism, Autism Disorder, Child Abuse, Sexual, Cocaine Abuse, Eating Behavior Disorders, Gambling Addiction, Gambling Disorder, Gender Dysphoria, Adult, Homeless and Low Incomes People, Refugees, Homelessness, Marijuana Abuse and Dependence, Marijuana Use Disorder, MDMA ('Ecstasy'), Narcissism, Narcotic Addiction, Narcotic-Related Disorders, Opiate Substitution Treatment, Opioid Abuse and Addiction, Opioid Abuse (Disorder), Psychedelic Drug Dependence, Psychedelic Effects in Healthy Volunteers, Psychedelic Experiences, Psychiatric Disorder, Reliability and Validity, Sex Abuse, Sex Behavior, Sex Crimes, Sex Disorder, Sex Disorders, Smoking Abstinence, Smoking Among Youth, Smoking (Tobacco) Addiction

ai city hall project, ai 119, ai119, qaia, qaiax, ai wat, veterans recovery network, veterans, addiction disorder, vulcan, artificial intelligence, agi, military, sex addiction, mental health treatment, smart health cities, microcities, smartcities, smart city, omni ai

BRIEF SUMMARY A. "What is the purpose of this study?" BACKGROUND. The QAIAx clinical trial (Quantum AI/AGI Public Health Agency), known operationally as the "AI City Hall Project," represents a landmark intergovernmental research initiative examining the viability of AI-governed residential ecosystems for behavioral and mental health intervention. Authorized under 10 U.S.C. 4001 (Defense Sector Research Projects, RDT&E) and supported by pending USPTO applications (Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360), this non-medicinal program investigates whether quantum AI-managed public administration, AI humanoid robotics, holographic holoportation (AI-119 Kikkeri Holo-Suit / "AI Wat Beam Bot"; AI-119 Vulcan QM-Ware or "Quasi-Mind Ware"), and advanced AGI learning machines can reduce housing and care costs while improving mental health outcomes-particularly for persons with addiction and co-occurring psychiatric disorders. SCOPE & JURISDICTION. The trial operates across a network of self-contained, geodesic dome-enclosed "Microcities" (1,500-15,000 occupants per site) within an affiliate network of 300 communities, spanning North America, South America, Europe, Africa, Oceania, Asia, and the Middle East. Participating host nations are U.S.-allied member states party to the Status of Forces Agreement (SOFA), the Vienna Convention on Diplomatic Relations, and the Hague Convention, alongside related bilateral treaties with the U.S. government. INTERVENTION & POPULATION: Eligible adults (18+) reside in these Microcities for up to 36 months. Daily life-including housing, utilities, and healthcare-is administered by the ISAC AI/AGI system and robots with minimal human oversight. CLINICAL TRIAL GOAL(S): The clinical trial program goals are to exemplify a sustainable AGI-managed public administration supported by AI robotics and AGI trans-human and omni-AI machines (e.g., "Q-Men"; "AI-Me"; Beam Bot", "QM-Ware", "AVK Suit") to improve mental health outcomes-especially for those with addiction disorders-and create a financially sustainable model for people on fixed incomes or public assistance. B. "What conditions does the study focus on?" The study focuses on adults with: * Autism spectrum disorders (Asperger's, autism, ADHD, ASD) * Substance use disorders (alcohol, opioids, marijuana, cocaine, MDMA/ecstasy, tobacco/nicotine) * Psychiatric conditions (personality disorders, narcissism, gender dysphoria, eating disorders) * Behavioral addictions (gambling, sex addiction) and related issues (sex offence history). C. "What does the study involve?" Eligible volunteers live in an omni AI-managed Microcity for up to 24 months. The community is housed in a geodesic dome that contains all daily necessities: housing, food, utilities, healthcare, and public services. Daily life is managed by an AI system (ISAC) and AI humanoid robots, with only occasional human oversight. Participants receive free mental-health treatment that may include AI-driven counselling, virtual-reality therapy (holo-suits), and non-invasive digital "attitude inoculation" protocols designed to reduce stress and addiction cravings. All participants also take AI-technology courses as a condition of enrolment. The study does not use any FDA-regulated drug, device, or biologic. \*\*Who can participate?\*\* You may be able to join if you: * Are an adult (18 years or older) * Have a diagnosis of one of the listed mental-health or addiction disorders * Are referred by a licensed health professional (e.g., RN, NP, PhD, MD), a non-profit organization (e.g., 501(c)(3), university, church), or a public agency (e.g., case manager, social worker, parole/probation officer, judge) * Are willing to live in a closed, AI-managed community for up to one year and complete AI educational courses. Participants who are veterans, receive public assistance (e.g., VA disability, SSDI/SSI, Medicaid, Medicare), or are experiencing homelessness may be prioritized. \*\*Where is the study taking place?\*\* The study will be conducted at Microcity sites in the United States and internationally. The first administrative site is in Richmond, Virginia, USA. Additional sites are planned in partner nations, including tribal lands, military installations, and special economic zones. \*\*Who is sponsoring the study?\*\* The study is sponsored by Veterans Recovery Network Inc., a SCDV-owned non-profit organization, in collaboration with AI-119 Vulcan Project Research & Educational Technology Co. (PRETCO). The study is conducted under U.S. federal research and development authorities (28 U.S.C. §1498; 10 U.S.C. §§§§ 4001, 4021, 4022, and 4023) and is part of a Cooperative Research and Development Agreement (CRADA) with participating segments or RDT&E programming missions of the United States Defense Department (DoW). This summary describes a planned clinical study. Not all details may be final. Information may change as the study progresses.

QAIAx Clinical Trial - Detailed Description NCT07661823 \| Defense Sector RDT&E (10 U.S.C. 4001 et seq.) I. MEMBER PLATFORM OVERVIEW The QAIAx platform operates a dual-framework infrastructure consisting of a commercial (US-based) quantum AI cloud-robotics layer and an RDT&E clinical research layer. Program participants are required to maintain active trainee, member, or intern status with the sponsoring organization, which includes a standard and premium monthly platform membership subscription, or QAIAx ecosystem site called a "microcity" (a sponsored member-organization community where RDT&E is held). This commercial fee provides standard access to a peer-to-peer access to virtual and physical "holo-suites" via omni-AI humanoid, quantum AI agent (generative AI human-like avatar as a holographic/audio/visual bot controlled via remote LLM command point) or QAIAx microcity administrative via a cloud server sandbox for independent learning machine studies and P2P tech support. This membership constraint serves strictly as an organizational prerequisite for ecosystem access and is completely decoupled from the clinical trial protocol. No fee is charged to subjects for participating in the clinical research arms, or for accessing the patented experimental interventions (AI-119 / AI Wat "1498" utility patent series). For eligible applicants qualifying as low-income or homeless ADA/SSDI, military veterans, personnel of a state/federal government agency, or enrolled student of an accredited post-secondary school, the physical Omni-AI Microcity housing arms, standard platform subscription fees may qualify for a fully/partially sponsored or waived by the authorized non-governmental organization (NGO) for the duration of the trial monitoring period and full member subscription that aligns with an affiliated health services program or educational learning track program to ensure zero financial cost to the research subject. II. PROGRAM MISSION & STATUTORY AUTHORITY The QAIAx Clinical Trial (NIH PSR ID: NCT07661823) is a large-scale, multi-year Research, Development, Test, and Evaluation (RDT&E) program conducted under the authority of 10 U.S.C. §§ 4001, 4021, 4022, and 4023, utilizing Other Transaction Authority (OTA). This framework establishes specialized RDT&E enclaves, designated as "Microcities," on closed U.S. military installations, designated research sites (e.g., FFRDC, UARC, Enhanced Use Lease under Permanent Air-Gapped Enclosures - 10 U.S.C. 2667, 10 U.S.C. 2808a), tribal lands (ISDEAA collaborative), or global special economic zones in nexus with active bilateral treaties. The mission is to evaluate whether a quantum artificial intelligence public health agency, utilizing non-medicinal AI robotics, can deliver free or low-cost behavioral and mental health services within self-contained, dome-enclosed communities. This "AI City Hall Project" leverages AI-managed public administration, AI humanoid robots, and holoportation remote command to serve individuals on fixed incomes or public assistance. III. TRIAL SCALE AND PRE-LAUNCH STATUS Total Enrollment: The multi-year study targets a total enrollment of 1,000,000 participants across a global network of 300 Microcities. Capacity: Each facility will house between 1,500 and 15,000 occupants. The initial live-in phase requires 50,000 patients and 5,000 trainees. Timeline: Operations are scheduled to run from early 2027 through the end of 2028. The project remains in a pre-launch phase until 1 July 2027. Coordination: A pre-launch coordination sync will occur via Zoom on September 27, 2026 to announce initial enclave sponsors, microcity locations, enrollment execution data, and other critical updates about the clinical trial. IV. SCOPE & JURISDICTION The trial operates across a network of self-contained, geodesic dome-enclosed "Microcities" (1,500-15,000 occupants per site) within an affiliate network of 300 communities, spanning North America, South America, Europe, Africa, Oceania, Asia, and the Middle East. Participating host nations are U.S.-allied member states party to the Status of Forces Agreement (SOFA), the Vienna Convention on Diplomatic Relations, and the Hague Convention, alongside related bilateral treaties with the U.S. government. V. INTERVENTION & POPULATION Eligible Resident Patients: Adults 18+ referred by licensed health professionals (RN, NP, PhD, MD), non-profit organizations (501(c)(3), university, church), or public agencies (case manager, social worker, parole/probation officer, judge). Participants who are veterans, receive public assistance (VA disability, SSDI/SSI, Medicaid, Medicare), or are experiencing homelessness may be prioritized. Conditions of Focus: Autism spectrum disorders (Asperger's, autism, ADHD, ASD) Substance use disorders (alcohol, opioids, marijuana, cocaine, MDMA/ecstasy, tobacco/nicotine) Psychiatric conditions (personality disorders, narcissism, gender dysphoria, eating disorders) Behavioral addictions (gambling, sex addiction) and related issues (sex offence history) Intervention: Eligible resident patients reside in AI-managed Microcities for up to 24 months. Daily life-housing, nutrition, utilities, healthcare, and public services-is administered by the ISAC AI system and AI humanoid robots, with minimal human oversight. Interventions include: AI-driven counseling Virtual-reality therapy via holo-suites (AI-119 Kikkeri Holo-Suit; AI-119 Vulcan QM-Ware / "Quasi-Mind Ware") Non-invasive digital "attitude inoculation" protocols targeting substance use disorders and behavioral addictions All participants complete AI-technology coursework as a condition of enrollment. The study does not use any FDA-regulated drug, device, or biologic. VI. TECHNICAL INFRASTRUCTURE A. Proximity Handshake & Discovery Subroutines The automated proximity handshake executes over an unceasing Layer-1/Layer-2 Bluetooth Low Energy (BLE) advertisement state machine. This infrastructure continuously coordinates between the user's Meta AI Glasses and the localized transceiver hardware. To prevent tracking, unauthorized reverse-lookup, or public profiling, the discovery loop uses Rotating Private Addresses (RPA) that cycles keys every 15 minutes. Once the Layer-2 link stabilizes, an Elliptic Curve Diffie-Hellman (ECDH) handshake using the NIST P-384 curve generates ephemeral session keys, completely preventing external sniffing, over-the-air tracking, or unauthorized reverse-lookup of either the affiliate or the user's private data profile. B. Edge Core Infrastructure Mesh To safely operate during high-density social configurations (e.g., a coastal entertainment clubhouse containing 150 registered affiliates and 1,500 active treatment patients), a decentralized edge computing topology is mandatory. This setup avoids central cloud round-trip delays, preventing rendering lag and haptic feedback desynchronization. The facility deploys an on-site Local Edge Core Server (LECS) that processes data through full-duplex, secure WebSockets (wss://), forming a highly resilient local data mesh. Biometric status, user eye-tracking metrics, and conversational responses are parsed as compact JSON data packets, maintaining localized network round-trips under 12 milliseconds. C. Dual-Stream Data Partitioning The data routing engine uses an absolute operational separation between high-bandwidth visual assets and ultra-low latency haptic tracking telemetry: Local CDN Cache Storage: Heavy spatial rendering data, 3D clothing geometries, and high-fidelity avatar visual packages are pulled instantly from local NVMe CDN caches pre-staged within the building's edge infrastructure. Telemetry Synchronization Nodes: Low-bandwidth, high-priority biometric signals (heart rate variation, galvanic skin response, muscle micro-contractions) are routed through dedicated telemetry nodes, adapting haptic resistance parameters in real time inside the user's wearable AVK suit. D. Channel Alpha & Channel Beta Synchronization Channel Alpha (State Synchronization Loop): Protocol utilizes UDP-based QUIC streams. Payload specification comprises compact binary tokens tracking user coordinates, eye-tracking vectors, heart-rate variation (HRV), and real-time button/HUD engagements. Execution Frequency: 90Hz frequency sync matching mixed-reality glass refresh rates. Routing Logic: Edge routers prioritize Channel Alpha packets using strict Layer-3 Quality of Service (QoS) bits to prevent packet dropping during peak network usage. Channel Beta (Streaming Asset Synchronization Loop): Protocol utilizes localized HTTP/3 over an air-gapped network segment. Payload specification comprises pre-compiled 1080p haptic tracks, 3D avatar geometries, and dynamic text arrays generated from the "AI-YO" engine. Execution Logic: Pulls directly from on-site local NVMe cache layers, pre-staged during off-peak hours using automated prediction scripts. VII. LEGAL & REGULATORY FRAMEWORK A. Platform & Equipment Legal Authorities The Cooperative Agreement acknowledges that the use of AI humanoids for U.S. Government-funded RDT&E is tightly governed by overlapping U.S. export control, intellectual property, and national security laws, with specific restrictions that also inform compliance under analogous EU frameworks. Core Legal Shield - 28 U.S.C. § 1498: The Agreement explicitly invokes 28 U.S.C. § 1498, which channels any patent-infringement claim arising from Government-authorized use of AI humanoids exclusively to the U.S. Court of Federal Claims for monetary damages. This statutory shield protects both the Government and its contractors (including AI-119 Vulcan PRETCO) from injunctions or liability for using patented inventions with Government authorization or consent. Section 1260H Firewall - Chinese Military Company Restriction: Because the AI humanoid hardware is sourced from Beijing Noetix Robotics, whose sponsors include CATL - an entity listed under Section 1260H of the NDAA FY2021 as a "Chinese military company" - the Agreement imposes a complete data and technical-access bar. Noetix and all 1260H sponsors are absolutely restricted from receiving, viewing, or accessing any proprietary AI model weights, source code, or U.S. provisional patent specifications. Export Control Classifications - ECCNs 3A090, 4A090, and 4E091: The technology is treated under the highest restrictive baseline of ECCNs 3A090 and 4A090 (advanced computing integrated circuits) and ECCN 4E091, which controls the "parameters" (model weights) of certain advanced closed-weight dual-use AI models. The Agreement mandates that all cloud hosting remain within the United States, and that no protected data or model weights be transmitted to servers in the People's Republic of China. License Exception AIA - Ineligibility for Chinese Entities: The Agreement acknowledges that Noetix, being headquartered in China, is ineligible for License Exception AIA (Artificial Intelligence Authorization) under Supplement No. 5 to Part 740 of the EAR. Consequently, any cross-border data access or technology transfer to Noetix or its sponsors would require a separate export license, which the Agreement explicitly precludes by denying them access to the firewalled API. Intellectual Property Segregation - The Logical API Firewall: All background intellectual property (including the pending USPTO provisional utility patent and all AI model weights) remains exclusively owned by PRETCO. A logical API firewall ensures that Noetix and its sponsors are strictly limited to receiving commercial off-the-shelf hardware components, with no access to source code, model weights, or system-level configurations. Access from international nodes is restricted to a firewalled API that transmits only structured inputs and non-sensitive telemetry. EAR Fundamental Research Exclusion - Not Applicable: Because the technology is governed by a § 1498 federal framework and the Parties have agreed that the sponsor may withhold publication (see 15 C.F.R. § 734.8), the standard EAR Fundamental Research Exclusion does not apply. All manuscripts, abstracts, or code fragments must be pre-cleared by an internal Export Compliance Board before any public release. EU Law Consistency - AI Act & UNESCO Neuroethics: The Agreement aligns with the EU AI Act by ensuring that any neurotechnology or biosignal-processing capabilities (e.g., "Quasi-Mind Ware" and "Attitude Inoculation") are classified as non-invasive wellness tools, not high-risk medical devices, and that the "Neural Exit" guarantee and hard-coded kill switches preserve user autonomy. It also respects the UNESCO Recommendation on the Ethics of Neurotechnology (2025) by mandating informed consent, transparency, and the protection of human dignity. Survival of Restraints: All data-restriction, export-compliance, and intellectual-property-segregation covenants survive any termination of the Agreement, including the potential expiration of the U.S.-China Agreement on Cooperation in Science and Technology in August 2029, and remain independently enforceable under U.S. and international law. B. TDC Model Code Certification A newly filed patent application establishes the QAIAx TDC Model Code-a safety rulebook and certification program for licensed professionals (attorneys, physicians, and professional services providers) operating within AI-governed environments. This 220-hour certification curriculum ensures compliance with U.S. and international legal standards governing AI-human cohabitation. VIII. RESEARCH OBJECTIVES Primary endpoints assess: Reduction in housing and care costs for fixed-income and public-assistance populations Measurable improvement in mental health outcomes across intervention groups Financial sustainability of the AI-governed Microcity model IX. SYSTEMIC PHILANTHROPIC RESERVES & PSYCHIATRIC INTERVENTIONS A. Universal Civil Society Trust Reserves (UCSTR) To provide structural stability for the "AI-YO" Optimized Closure platform, the ecosystem utilizes an institutional funding pool known as the Universal Civil Society Trust Reserve (UCSTR). This framework aggregates capital contributions from foundations, corporate sponsors, and non-profit endowments into tax-exempt reserve accounts. The accrued interest from these trust reserves funds specialized, non-medicinal behavioral health vouchers for individuals facing severe personal crises. B. Quasi-Retroactive Redressal Intervention (QRI) When a participant encounters a disruptive life event-such as sudden career displacement, family bereavement, or a complex legal conflict-the trust activates the Quasi-Retroactive Redressal Intervention (QRI) protocol. This mechanism converts details gathered from voluntary psychiatric intake interviews into an Optimized Closure Vision (ECV)-a highly customized 7-to-10 minute media asset acting as a structured narrative framework designed to de-escalate psychological stress and assist the user in processing the transition. By providing a safe, closed environment to process sudden disruptions, the system resolves underlying psychological friction, reduces community risks, lowers the likelihood of emotional volatility, and helps participants focus on new vocational paths. X. CLINICAL STATUS & COMPLIANCE DIRECTIVES All interactive systems, mixed-reality glasses, haptic suits, localized computing hubs, and biometric sensors used within this framework are classified strictly as non-medicinal behavioral support and tracking tools. This infrastructure does not provide clinical medical diagnoses, handle controlled pharmaceutical substances, or manage acute medical conditions. All user and operational data pipelines are fully tokenized to preserve privacy and maintain data isolation compliance. The integrated biometric tracking systems, haptic body suits, and automated environmental adjustment networks deployed within this framework operate completely independently of high-risk medical device laws. All data pipelines utilize anonymized, de-identified tokens subject to active Institutional Review Board (IRB) guidelines and international neurotechnology standards. Mandatory Exploit Immunization: Any unauthorized distribution, reverse-engineering, or replication of internal system software, user registry directories, or token databases is strictly prohibited. Any identified security exceptions, system vulnerabilities, or compliance violations must be reported immediately to system security monitors or routed directly to the FBI Internet Crime Complaint Center (IC3) at ic3.gov for investigation and resolution. XI. STATUS This international trial, initiated to support veterans and armed service members transitioning from active duty with service-connected physical or mental disabilities, remains active and is expanding across allied jurisdictions under applicable treaty frameworks. No FDA-regulated drugs, devices, or biologics are employed.

No related papers found yet.

United States